Influence of matrix application timing on spectral reproducibility and quality in SELDI-TOF-MS

被引：13

作者：

Jock, CA

Paulauskis, JD

Baker, D

Olle, E

Bleavins, MR

Johnson, KJ

Heard, PL

机构：

[1] Pfizer Global Res & Dev, Ann Arbor, MI 48105 USA

[2] Univ Michigan, Sch Med, Ann Arbor, MI USA

来源：

BIOTECHNIQUES | 2004年 / 37卷 / 01期

关键词：

D O I：

10.2144/04371BM01

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：30 / +

页数：4

共 10 条

[1]

Beavis RC, 1996, METHOD ENZYMOL, V270, P519

[2] Multifactorial screening design and analysis of SELDI-TOF ProteinChip® array optimization experiments [J].

Cordingley, HC ;

Robets, SLL ;

Tooke, P ;

Armitage, JR ;

Lane, PW ;

Wu, W ;

Wildsmith, SE .

BIOTECHNIQUES, 2003, 34 (02) :364-+

[3]

Dare TO, 2002, ELECTROPHORESIS, V23, P3241, DOI 10.1002/1522-2683(200209)23:18<3241::AID-ELPS3241>3.0.CO

[4]

2-D

[5]

Fung ET, 2000, CURR OPIN MOL THER, V2, P643

[6] SELDI-TOF MS for diagnostic proteomics. [J].

Issaq, HJ ;

Conrads, TP ;

Prieto, DA ;

Tirumalai, R ;

Veenstra, TD .

ANALYTICAL CHEMISTRY, 2003, 75 (07) :148A-155A

[7] Cystatin C as a cerebrospinal fluid biomarker for pain in humans [J].

Mannes, AJ ;

Martin, BM ;

Yang, HYT ;

Keller, JM ;

Lewin, S ;

Gaiser, RR ;

Iadarola, MJ .

PAIN, 2003, 102 (03) :251-256

[8]

Merchant M, 2000, ELECTROPHORESIS, V21, P1164, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.3.CO

[9]

2-S

[10] Use of proteomic patterns in serum to identify ovarian cancer [J].

Petricoin, EF ;

Ardekani, AM ;

Hitt, BA ;

Levine, PJ ;

Fusaro, VA ;

Steinberg, SM ;

Mills, GB ;

Simone, C ;

Fishman, DA ;

Kohn, EC ;

Liotta, LA .

LANCET, 2002, 359 (9306) :572-577

← 1 →